Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Sonoma Pharmaceuticals Inc (SNOA)

Sonoma Pharmaceuticals Inc (SNOA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 98,821
  • Shares Outstanding, K 19,004
  • Annual Sales, $ 12,740 K
  • Annual Income, $ -4,840 K
  • 60-Month Beta 1.37
  • Price/Sales 0.32
  • Price/Cash Flow N/A
  • Price/Book 0.67
Trade SNOA with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -4.00
  • Growth Rate Est. (year over year) +25,075.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.70 +59.01%
on 09/03/24
5.93 -27.49%
on 09/17/24
-0.70 (-14.00%)
since 08/16/24
3-Month
2.70 +59.01%
on 09/03/24
9.37 -54.13%
on 07/11/24
+0.46 (+11.98%)
since 06/18/24
52-Week
2.32 +85.50%
on 11/10/23
18.20 -76.37%
on 09/19/23
-13.90 (-76.37%)
since 09/18/23

Most Recent Stories

More News
Sonoma Pharmaceuticals Announces Partnership with Global Healthcare Distributor for Distribution of Wound Care Products in the United States

BOULDER, CO / ACCESSWIRE / August 21, 2024 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous...

SNOA : 4.30 (-17.31%)
Investors Chat: Instacart IPO

Instacart is profitable and growing. Is that enough to spark investor interest?

LYV : 102.80 (-0.12%)
WMT : 79.03 (+0.55%)
MCD : 292.03 (-0.59%)
DIS : 93.58 (+0.78%)
CPB : 51.08 (-0.85%)
UBER : 73.50 (+0.99%)
DASH : 132.48 (+2.00%)
NFLX : 690.47 (-2.33%)
AMZN : 186.43 (-0.24%)
PEP : 175.21 (-0.94%)
SNOA : 4.30 (-17.31%)
Augmented Reality Devices: Apple vs. Meta Platforms

Plus, how to plan for a healthier retirement.

AAPL : 220.69 (+1.80%)
TMUS : 196.68 (-2.97%)
META : 537.95 (+0.30%)
SNOA : 4.30 (-17.31%)
COIN : 162.64 (+0.12%)
VZ : 43.88 (-0.45%)
T : 21.73 (-0.23%)
UBER : 73.50 (+0.99%)
Sonoma Pharmaceuticals (NASDAQ: SNOA) and EMC Pharma Receives DAPA Registration for Microcyn Rx Products from U.S. Department of Defense

Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) is a global healthcare company that is focused on the research, development and production of

SNOA : 4.30 (-17.31%)
Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2022 Financial Results

WOODSTOCK, GA / ACCESSWIRE / July 13, 2022 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA),a global healthcare leader developing and producing patented Microcyn® technology-based stabilized hypochlorous...

SNOA : 4.30 (-17.31%)
Sonoma Pharmaceuticals and MicroSafe Group DMCC Announce that U.S. EPA has Added Nanocyn® Hospital-Grade Disinfectant to List N for Use Against COVID-19

Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing patented Microcyn® technology-based stabilized hypochlorous acid (HOCl) products for a wide range of applications,...

SNOA : 4.30 (-17.31%)
Sonoma Pharmaceuticals and MicroSafe Group DMCC Announce EPA Approval for Nanocyn® Hospital-Grade Disinfectant in the U.S.

Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing patented Microcyn® technology-based stabilized hypochlorous acid (HOCl) products for a wide range of applications,...

SNOA : 4.30 (-17.31%)
Sonoma Pharmaceuticals Launches New Urinary Tract Infection Product Through Distributors in New Zealand, Australia and South Africa

Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications,...

SNOA : 4.30 (-17.31%)
Sonoma Pharmaceuticals Reports Third Quarter FY 2022 Financial Results

Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye...

SNOA : 4.30 (-17.31%)
Sonoma Pharmaceuticals Announces Expansion of its Partner Network for Oral and Dental Products in the U.S. and China

Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing patented Microcyn® technology-based stabilized hypochlorous acid (HOCl) products for a wide range of applications,...

SNOA : 4.30 (-17.31%)

Business Summary

Sonoma Pharmaceuticals operates as a pharmaceutical company. It develops and markets solutions for the treatment of dermatological conditions, animal health and advanced tissue care. The company operates primarily in United States, Latin America and Europe. Sonoma Pharmaceuticals formerly known as Oculus...

See More

Key Turning Points

3rd Resistance Point 6.56
2nd Resistance Point 5.85
1st Resistance Point 5.07
Last Price 4.30
1st Support Level 3.58
2nd Support Level 2.87
3rd Support Level 2.09

See More

52-Week High 18.20
Fibonacci 61.8% 12.13
Fibonacci 50% 10.26
Fibonacci 38.2% 8.38
Last Price 4.30
52-Week Low 2.32

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar